LOCALIZED UNRESECTABLE ADULT PRIMARY LIVER CANCER

Clinical trials for LOCALIZED UNRESECTABLE ADULT PRIMARY LIVER CANCER explained in plain language.

Never miss a new study

Get alerted when new LOCALIZED UNRESECTABLE ADULT PRIMARY LIVER CANCER trials appear

Sign up with your email to follow new studies for LOCALIZED UNRESECTABLE ADULT PRIMARY LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New immunotherapy cocktail targets tough liver tumors

Disease control Ongoing

This phase II trial tests whether combining two immunotherapy drugs (cobolimab and dostarlimab) can shrink or slow advanced liver cancer that cannot be removed by surgery. About 42 adults with a specific type of liver cancer (hepatocellular carcinoma) and mild-to-moderate cirrhos…

Matched conditions: LOCALIZED UNRESECTABLE ADULT PRIMARY LIVER CANCER

Phase: PHASE2 • Sponsor: University of Hawaii • Aim: Disease control

Last updated May 12, 2026 13:40 UTC

LOCALIZED UNRESECTABLE ADULT PRIMARY LIVER CANCER

Get alerted when new LOCALIZED UNRESECTABLE ADULT PRIMARY LIVER CANCER trials appear

New immunotherapy cocktail targets tough liver tumors